Invasive meningococcal disease in children in Ireland, 2001–2011

Maoldomhnaigh, Cilian Ó; Drew, Richard J.; Gavin, Patrick J.; Cafferkey, Mary T.; Butler, Karina

doi:10.1136/archdischild-2015-310215

Cited by 22 publications

(26 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The incidence of sequelae in our study was 3%, but only severe, permanent sequelae were registered. This was lower than the percentage registered in many other studies, where the incidence of sequelae was reported to be 8–19% . One explanation for this difference could, of course, be differences in the registration criteria, with variations between suspected, smaller and severe sequelae.…”

Section: Discussioncontrasting

confidence: 67%

An epidemic of meningococcal disease in children in North Norway in the 1970s and 1980s was dominated by a hypervirulent group B strain

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 67%

An epidemic of meningococcal disease in children in North Norway in the 1970s and 1980s was dominated by a hypervirulent group B strain

et al. 2017

View full text Add to dashboard Cite

show abstract

“…До речі, нещодавній аналіз результатів лікування 1820 випадків інвазивної МІ у дітей в Ірландії протягом 2001-2011 рр. констатує лише 3,6 % летального кін-ця, що різко контрастує з вітчизняними показника-ми летальності [8].…”

Section: актуальність проблемиunclassified

Інтенсивна Терапія Тяжких Та Блискавичних Форм Менінгококової Інфекції В Дітей

Heorhiiants¹,

Корсунов²

2022

ЕМ

View full text Add to dashboard Cite

mentioning

confidence: 99%

“…1,2 The early diagnosis of MD significantly improves outcomes with reduced morbidity and mortality. 1,2 The early stages of MD are often indistinguishable from a simple viral illness making an early positive diagnosis of MD difficult. 1 Hibergene have developed a commercially available bedside Loop-mediated isothermal AMPlification PCR (LAMP-MD) test that is a highly sensitive 0.89 (95%CI 0.72-0.96) and specific 1.0 (95%CI 0.97-1.0) for identifying children with invasive MD (4) (figure 1).…”

mentioning

confidence: 99%

53 Piloting patch – providing assessment and treatment for children at home – and piecing together what works

Ward¹,

Knight²,

Ballard³

et al. 2017

Emerg Med J

View full text Add to dashboard Cite

AimsPATCH is a pilot acute community children’s nurse led service delivering assessment and treatment for children at home who are moderately unwell and might otherwise be admitted to hospital or attend Paediatric Emergency Department (PED). Children are referred by PED or GP and followed up via telephone support and home visits depending on clinical need for duration of acute illness.MethodsPilot year funded by Imperial Charity. Using evaluation to build business case for sustained commissioned service. Phase 1 Sept 2016 – May 2017 : reduced short stay admissions and re-attendances to PED for common mild-moderate respiratory conditions e.g., viral wheeze, bronchiolitis. Phase 2 from May 2017 : piloting direct GP referrals to PATCH team to evaluate impact in reducing attendances to PED for children needing further assessment or support beyond GP consultation, and enabling families to manage common acute conditions at home.Using QI methodology, Model for Improvement we developed a driver diagram and used real-time PDSA cycles to capture our learning and inform small iterative changes of service development. Process mapping and world cafe style events were held with local community nurses, health visitor leads, GPs and commissioners to co-design referral pathways and explore more widely how PATCH fits into the whole urgent care system.Figure 1Parental feedback evaluated via semi structured interviews.ResultsActivity – Appendix 1Phase 1 – Concentrated on respiratory conditions from PED.Total 188 referrals in first 7 months. Bronchiolitis 45%; viral wheeze 37.5%; asthma 7%; lower respiratory tract infections 5.4%.Figure 250% of patients received home visits and telephone consultations; 50% only telephone support.Successes: Cost effective – Appendix 273 acute admissions avoided, costing c£400 per/night97 PED re-attendances prevented at £117 per attendance.Projected cost avoidance within acute care provider £3 27 640 pa.Estimated cost of service £2 84 000 pa.Positive feedback and reported health seeking behaviour change – Appendix 3ChallengesInformation governance, cross organisational working, complex commissioning arrangements.Figure 3DiscussionWithin first 7 months PATCH has had a significant impact on avoiding admissions and re-attendances, thus improving flow and performance in PED. The projected financial impact is that it is cost effective.We are using this data to pursue a business case internally and with local CCGs. We are optimistic of succeeding and using phase 2 to build on partnerships garnered across the whole system to expand PATCH’s impact further by reducing PED attendances and continuing to improve our local urgent care pathway for children.

show abstract

Invasive meningococcal disease in children in Ireland, 2001–2011

Cited by 22 publications

References 14 publications

An epidemic of meningococcal disease in children in North Norway in the 1970s and 1980s was dominated by a hypervirulent group B strain

An epidemic of meningococcal disease in children in North Norway in the 1970s and 1980s was dominated by a hypervirulent group B strain

Інтенсивна Терапія Тяжких Та Блискавичних Форм Менінгококової Інфекції В Дітей

53 Piloting patch – providing assessment and treatment for children at home – and piecing together what works

Contact Info

Product

Resources

About